Cannabichromene (Cannabics Pharmaceuticals)

N/A

Report date: 2024/04/07 16:16:32

Base Information

Drug NameCannabichromene (Cannabics Pharmaceuticals)
Drug Alias NameCBCA (Cannabics Pharmaceuticals)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCannabinoid receptor modulators
TargetsCannabinoid receptor
Therapy Area/IndicationsColonic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCNBX Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesCNBX Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsColonic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A